Open AccessEfficacy and safety of human chorionic gonadotropin combined with human menopausal gonadotropin and a gonadotropin-releasing hormone pump for male adolescents with congenital hypogonadotropic hypogonadism
Author(s) -
Ying Liu,
Xiaohan Ren,
Yaguang Peng,
Shao-Ke Chen,
Xinran Cheng,
Miao Qin,
Xiaoling Wang,
Yanning Song,
Lijun Fan,
Chunxiu Gong
Publication year - 2021
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000001419
Subject(s) - human chorionic gonadotropin , gonadotropin , hypogonadotropic hypogonadism , medicine , endocrinology , gonadotropin releasing hormone , hormone , luteinizing hormone
Compared to adult studies, studies which involve the treatment of pediatric congenital hypogonadotropic hypogonadism (CHH) are limited and no universal treatment regimen is available. The aim of this study was to evaluate the feasibility of human chorionic gonadotropin (hCG)/human menopausal gonadotropin (hMG) therapy for treating male adolescents with CHH.